Filing Details

Accession Number:
0001104659-19-039283
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-03 16:00:30
Reporting Period:
2019-07-01
Accepted Time:
2019-07-03 16:00:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Iveric Bio Inc. ISEE Pharmaceutical Preparations (2834) 208185347
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703623 Francis David Carroll C/O Iveric Bio, Inc.
One Penn Plaza, 35Th Floor
New York NY 10119
Svp, Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-01 7,500 $0.00 16,480 No 4 M Direct
Common Stock Disposition 2019-07-02 2,773 $1.25 13,707 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-07-01 7,500 $0.00 7,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2026-06-30 No 4 M Direct
Footnotes
  1. Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
  2. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on July 1, 2019.
  3. On July 1, 2016, the reporting person was granted an award of 30,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan.